![]() |
Ad hoc: Celesio AG: Celesio AG acquires majority stake in DocMorris | ![]() |
Thursday, 26. April 2007 10:20 |
---|
Stuttgart, 26 April 2007 - Today the Supervisory Board of Celesio AG has approved the share purchase agreement on the acquisition of circa 90% of the share capital of WWMW e-commerce international GmbH, the holding company of the DocMorris-group. The remaining circa 10% of the share capital are being held by the management of DocMorris. Through this acquisition Celesio gets hold of the only pharmacy brand which is known all over Germany. By doing so, Celesio sets a clear signal against discounters and both national and international interested parties without a traditional relation to the pharmacy business. At the same time, Celesio establishes the basis for strengthening the market position of the customers of its German subsidiary GEHE. DocMorris will remain legally independent within the Celesio-group. The acquisition is subject to clearance by the German Competition Council (Bundeskartellamt). Celesio AG Neckartalstraße 155 70376 Stuttgart Germany Contact: Rainer Berghausen +49.711.5001-549 End of ad-hoc release. WKN: CLS 100; ISIN: DE000CLS1001 Indices: CDAX, MDAX, Prime All Share, CLASSIC All Share, HDAX, MIDCAP Listed: Official market in Berlin-Bremen, Düsseldorf, Francfurt (Prime Standard), Munich, Stuttgart; unofficial regulated market in Hamburg and Hanover --- End of Message --- Celesio AG Neckartalstrasse 155 Stuttgart Germany WKN: CLS100; ISIN: DE000CLS1001; Index: CDAX, MDAX, Prime All Share, CLASSIC All Share, HDAX, MIDCAP; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Amtlicher Markt in Bayerische Börse München, Amtlicher Markt in Börse Düsseldorf, Amtlicher Markt in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Amtlicher Markt in Börse Berlin Bremen; |
Related Links: McKesson Europe AG |
Author: Hugin Copyright GlobeNewswire, Inc. 2016. All rights reserved. You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account. |